David Leahy

Current

• CEO at Inkspot Science
• Professor of Practice at Newcastle University

Past

• Independent Research Scientist at
• Chief Scientific Officer at Cyprotex
• Head of Physical Sciences at Zeneca Pharmaceuticals

Education

• University of East Anglia
• University of Cambridge

Connections

153 connections

Industry

Pharmaceuticals

Websites

• My Website

David Leahy’s Summary

Active in scientific innovations related to drug discovery for over 20 years, particularly interested in computer based drug design approaches incuding cheminfomatics, PBPK simulation and systems biology modelling.

Spent a number of years very focussed on experimental and software-based approaches to ADMET and pharmacokinetics.

More recently have become interested in developments around the semantic web, e-Science, Service-Oriented Architectures and the application of agent architectures to automate decision making drug design (www.discoverybus.com) Also active in developing new businesses in these areas and new businesses based on software as services concepts.

Main current research area is in automated decision making for drug design (www.discoverybus.com)

David Leahy’s Specialties:

QSAR
Drug discovery
Drug Discovery technology
Simulation approaches to systems biology
Autonomous agents applied to integration of molecular design algorithms
The semantic grid
service oriented architectures

Additional Information

David Leahy’s Websites:

• My Website

David Leahy’s Interests:

drug discovery innovation, agent systems, cheminformatics, open source drug discovery, Long Tail

David Leahy’s Contact Settings

Interested In:

• career opportunities
• new ventures
• expertise requests
• business deals
• reference requests
• getting back in touch